The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

Abandoning efforts to reform payment for cell and gene therapies for Medicaid beneficiaries could allow ongoing access ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

With a majority vote by the Senate Finance Committee, Robert F. Kennedy Jr's nomination for health secretary is pushed to a ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

World Cancer Day also marks the start of the ‘United by Unique’ campaign, which seeks to highlight how each person’s journey ...

New research highlights the significant health care resource utilization burden of generalized pustular psoriasis (GPP), ...

A new meta-analysis adds to the body of literature promoting the benefits of exercise for patients with cancer.

Insurance coverage of preventive care is on the line as Braidwood Management v Becerra moves to the Supreme Court this year.

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...